 Shares of Applied DNA Sciences Inc. APDN, 390.46 skyrocketed 353.7 higher in very volatile trading Tuesday, after the biotechnology company said it initiated validation of a monkeypox virus test. Trading volume spiked to 73.1 million shares, compared with the full-day average of about 256,450 shares. 